Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae.
Boutal H, Vogel A, Bernabeu S, Devilliers K, Creton E, Cotellon G, Plaisance M, Oueslati S, Dortet L, Jousset A, Simon S, Naas T, Volland H. Boutal H, et al. Among authors: vogel a. J Antimicrob Chemother. 2018 Apr 1;73(4):909-915. doi: 10.1093/jac/dkx521. J Antimicrob Chemother. 2018. PMID: 29365094 Free PMC article.
False-Positive Carbapenem-Hydrolyzing Confirmatory Tests Due to ACT-28, a Chromosomally Encoded AmpC with Weak Carbapenemase Activity from Enterobacter kobei.
Jousset AB, Oueslati S, Bernabeu S, Takissian J, Creton E, Vogel A, Sauvadet A, Cotellon G, Gauthier L, Bonnin RA, Dortet L, Naas T. Jousset AB, et al. Among authors: vogel a. Antimicrob Agents Chemother. 2019 Apr 25;63(5):e02388-18. doi: 10.1128/AAC.02388-18. Print 2019 May. Antimicrob Agents Chemother. 2019. PMID: 30783006 Free PMC article.
A Lateral Flow Immunoassay for the Rapid Identification of CTX-M-Producing Enterobacterales from Culture Plates and Positive Blood Cultures.
Bernabeu S, Ratnam KC, Boutal H, Gonzalez C, Vogel A, Devilliers K, Plaisance M, Oueslati S, Malhotra-Kumar S, Dortet L, Fortineau N, Simon S, Volland H, Naas T. Bernabeu S, et al. Among authors: vogel a. Diagnostics (Basel). 2020 Sep 28;10(10):764. doi: 10.3390/diagnostics10100764. Diagnostics (Basel). 2020. PMID: 32998433 Free PMC article.
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma.
Sangro B, Galle PR, Kelley RK, Charoentum C, De Toni EN, Ostapenko Y, Heo J, Cheng AL, Wilson Woods A, Gupta C, Abraham J, McCoy CL, Patel N, Negro A, Vogel A, Abou-Alfa GK. Sangro B, et al. Among authors: vogel a. J Clin Oncol. 2024 May 28:JCO2301462. doi: 10.1200/JCO.23.01462. Online ahead of print. J Clin Oncol. 2024. PMID: 38805668
Evidence and Choice: The BCLC Vision for Tailoring Clinical Decision-Making.
Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Fuster J, Ayuso C, Bruix J. Reig M, et al. Among authors: vogel a. J Hepatol. 2024 May 8:S0168-8278(24)00321-0. doi: 10.1016/j.jhep.2024.04.023. Online ahead of print. J Hepatol. 2024. PMID: 38729354 No abstract available.
1,611 results